SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE:A) today introduced Agilent GeneSpring GX 10.0, the next generation of Agilent’s flagship gene expression bioinformatics platform. GeneSpring GX, considered the gold standard of desktop gene expression analysis, now offers tools for systems-level data interpretation and pathway analysis, enabling scientists to attain a new level of insight into the underlying mechanism of disease or biological process.
